Pathology of lupus nephritis

Lupus

Volumn 14, Issue 1, 2005, Pages 31-38

  Lewis, Edmund J ^a,b   Schwartz, M M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Classification; Glomerulonephritis; Immune complexes; Necrosis; Thrombosis

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; POLYNUCLEOTIDE;

ANTIGEN ANTIBODY COMPLEX; BLOOD VESSEL INJURY; CAPILLARY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA PROTEIN COMPLEX; EXPERIMENTAL MODEL; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS CAPILLARY; IMMUNE ADHERENCE; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; INFLAMMATION; INTERNATIONAL SOCIETY OF NEPHROLOGY CLASSIFICATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM CELL; OUTCOMES RESEARCH; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; RELIABILITY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; THROMBOSIS;

ANTIBODIES, ANTINUCLEAR; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS;

EID: 13444252483     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2056oa     Document Type: Review

References (35)

1. Churg J, Sobin LH. Renal disease: classification and atlas of glomerular diseases. Tokyo, New York: Igaku-Shoin, 1982; 127-131.
2. Lewis EJ, Schwartz MM, Korbet SM. Severe lupus nephritis: importance of re-evaluating the histologic classification and the approach to patient care. J Nephrol 2001; 14: 223-227.
3. Churg J, Bernstein, Glassock RJ. Classification and atlas of glomerular diseases (second edition). Tokyo, New York: Igaku-Shoin 1995; 151-156.
4. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001; 59: 2156-2163.
5. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
6. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250.
7. Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988; 8: 85-89.
8. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading survival statistics for survival in cancer. N Engl J Med 1985; 312: 1604-1608.
9. Benacerraf B, Potter JL, McCluskey RT, Miller F. The pathologic effects of intravenously administered soluble antigen-antibody complexes. II. Acute glomulonephritis in rats. J Exptl Med 1960; 111: 195-200.
10. Fournie GJ. Circulating DNA and lupus nephritis. Kidney Int 1988; 33: 487-499.
11. Gallo GR, Coulin-Glaser T, Lamm ME. Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest 1981; 67: 1305-1313.
12. Wener MH, Mannik M, Schwartz MM, Lewis EJ. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) 1987; 66: 85-101.
13. Holdsworth SR. Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol 1999; 10: 499-506.
14. Kitching AR, Holdsworth SR, Tipping PG. IFN-γ mediates crescent formation in cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol 1999; 10; 752-759.
15. Couser WG. ed. Sensitized cells come of age: a new era in renal immunology with important therapeutic implications. J Am Soc Nephrol 1999; 10: 664-665.
16. Salant DJ, Madaio MP, Adler S, Stilmant MM. Altered glomerular permeability induced by F(ab')2 and Fab' antibodies to rat renal tubular epithelial antigen. Kidney Int 1982; 21: 36-43.
17. Kant KD, Pollak VE, Weiss ME, Glueck HI, Miller MA, Hess EV. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 1981; 60: 71-86.
18. Love PE, Santoro SA. Anti-phospholipid antibodies and the lupus anticoagulant in SLE and in SLE disorders. Ann Intern Med 1990; 112: 682-698.
19. LeTonqueze M, Salozhin K, Dueymes M. Role of β2-glycoprotein 1 in the antiphospholipid antibody binding to endothelial cells. Lupus 1995; 4: 179-186.
20. Lakos G, Kiss E, Regeczy N et al. Isotope distribution and clinical relevance of anti-beta-2-glycoprotein 1 antibodies. Importance of IgA isotope. Clin Exp Immunol 1999; 117: 574-579.
21. Nochy D, Daugas E, Droz D et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999; 10: 507-518.
22. Peddi VR, Kant KS. Catastrophic secondary antiphospholipid syndrome with concomitant antithrombin III deficiency. [Review]. J Am Soc Nephrol 1995; 5: 1882-1887.
23. Moake JL. Moschowitz, multimers and metalloprotease. N Engl J Med 1998; 339: 1629-1631.
24. Hertig A, Droz D, Lesavre P. Grunfeld J-P, Rieu P. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kid Dis 2002; 40: 1179-1184.
25. Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D'Agati VD. Minimal change disease in systemic lupus erythematosus. Clin Nephrol 2002; 57: 120-126.
26. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerulas podocytopathy in patients with systemic lupus erythematosus. J Amer Soc Nephrol. 2005; in press.
27. Austin HA, III, Muenz LR, Joyce KM et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983; 75: 382-391.
28. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med 1977; 62: 12-30.
29. Baldwin DS, Lowenstein J, Rothfield NF, Gallo G, McCluskey RT. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med 1970; 73: 929-942.
30. Marshall S, Dressler R, D'Agati V. Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 1997; 29: 119-124.
31. Muehrcke RC, Kark RM, Pirani CL, Pollak VE. Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine 1957; 36: 1-146.
32. Pollak VE, Pirani CL, Dujovne I, Dillard MG. The clinical course of lupus nephritis: relationship to the renal histologic findings. In Glomerulonephritis (vol 2), Kincaid-Smith P, Mathew TH, Becker EL ed. New York: John Wiley and Sons, 1973; 1167-1182.
33. Pollak VE, Pirani CL, Schwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med 1964; 63: 537-550.
34. Schwartz MM, Lan S-P, Bernstein J, Hill GS, Holley K, Lewis EJ. The Lupus Nephritis Collaborative Study Group: Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 1992; 42: 743-748.
35. Schwartz MM, Roberts JL, Lewis EJ. Necrotizing glomerulitis of systemic lupus erythematosus. Hum Pathol 1983; 14: 158-167.